lenalidomide has been researched along with Acquired Immune Deficiency Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gupta, NK; Mannis, GN; Rubenstein, JL; Wang, CC; Yu, JJ | 1 |
| Boué, F; Castilla, MA; Kirstetter, M; Martinez, V; Melica, G; Tateo, M | 1 |
2 other study(ies) available for lenalidomide and Acquired Immune Deficiency Syndrome
| Article | Year |
|---|---|
Regression of methotrexate-resistant AIDS-related primary central nervous system lymphoma with lenalidomide plus combination anti-retroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Central Nervous System Neoplasms; Drug Resistance, Viral; Female; Humans; Lenalidomide; Lymphoma, AIDS-Related; Thalidomide; Treatment Outcome | 2017 |
Lenalidomide in treating AIDS-related Kaposi's sarcoma.
Topics: Acquired Immunodeficiency Syndrome; HIV-1; Humans; Lenalidomide; Sarcoma, Kaposi; Skin Neoplasms; Thalidomide | 2011 |